Tiffany A. Glazer, MD

Associate Professor

  • Residency Program Director
  • Division of Otolaryngology-Head & Neck Surgery

glazer@surgery.wisc.edu
Office: (608) 265-8207

  • Clinical Appointments: (608) 263-6190

Education

  • MD, University of Wisconsin School of Medicine and Public Health, Madison, WI
  • Residency, Department of Otolaryngology – Head and Neck Surgery, University of Michigan; Ann Arbor, MI
  • Fellowship in Head & Neck Oncology and Microvascular Reconstructive Surgery, Department of Otolaryngology – Head and Neck Surgery, University of Michigan; Ann Arbor, MI

Clinical Specialties

Dr. Glazer is certified by the American Board of Otolaryngology-Head and Neck Surgery and is a member of the American Head and Neck Society. She is fellowship-trained in both head and neck oncology and microvascular reconstruction. Her specific areas of expertise include: head and neck cancer (all mucosal, upper aerodigestive tract, anterior skill base, and skin), reconstruction (both free tissue transfer and local flaps), Mohs reconstruction, neck mass, thyroid mass, and parotid mass. She also specializes in robotic surgery, laser surgery, and facial trauma.

Research Interests

Dr. Glazer conducts outcomes research in head and neck cancer patients and is highly invested in training the next generation of head and neck cancer surgeons.

Recent Publications

  • Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia.
    Blitzer GC, Paz C, Glassey A, Ganz OR, Giri J, Pennati A, Meyers RO, Bates AM, Nickel KP, Weiss M, Morris ZS, Mattison RJ, McDowell KA, Croxford E, Chappell RJ, Glazer TA, Rogus-Pulia NM, Galipeau J, Kimple RJ
    Radiother Oncol 2024 Mar; 192: 110093
    [PubMed ID: 38224919]

  • Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia.
    Blitzer GC, Glazer T, Burr A, Gustafson S, Ganz O, Meyers R, McDowell KA, Nickel KP, Mattison RJ, Weiss M, Chappell R, Rogus-Pulia NM, Galipeau J, Kimple RJ
    Cytotherapy 2023 Nov; 25(11): 1139-1144
    [PubMed ID: 37589639]

  • Contrast tomography (CT) performed to detect nodal metastasis for high-risk cutaneous squamous cell carcinomas of the head and neck has a high negative predictive value but a poor positive predictive value.
    Rudningen K, Sable KA, Glazer TA, Hu R, Lasarev MR, Xu YG
    JAAD Int 2023 Dec; 13: 37-38
    [PubMed ID: 37663165]

  • A combined, supraclavicular, infraclavicular, transaxillary, and posterior subscapular approaches for en bloc resection of giant myxofibrosarcoma.
    Bethel JA, McCarthy DP, Weisman PS, Glazer TA, Hanna AS
    Surg Neurol Int 2023; 14: 144
    [PubMed ID: 37151449]

  • Management of Subglottic Cancer.
    Mann H, Seligman K, Colwell N, Burr A, Glazer TA
    Otolaryngol Clin North Am 2023 Apr; 56(2): 305-312
    [PubMed ID: 37030943]

All Publications on PubMed